CAMBRIDGE NUTRITIONAL SCIENCES PLC Cambridge Nutritional Sciences plc Stock
Equities
ODX
GB00B1VCP282
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4 GBX | +8.11% |
|
+19.40% | +66.67% |
| Apr. 22 | Cambridge Nutritional Sciences Nonexecutive Chair Steps Down; Successor Named | MT |
| Apr. 22 | Cambridge Nutritional Sciences plc Provides Earnings Guidance for the Year Ended 31 March 2024 | CI |
| Sales 2024 * | 9M 11.16M | Sales 2025 * | - | Capitalization | 8.8M 10.92M |
|---|---|---|---|---|---|
| Net income 2024 * | -1M -1.24M | Net income 2025 * | - | EV / Sales 2024 * | 0.51 x |
| Net cash position 2024 * | 4.2M 5.21M | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
| P/E ratio 2024 * |
-7.4
x | P/E ratio 2025 * |
-
| Employees | 91 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.83% |
More Fundamentals
* Assessed data
More news
Latest transcript on Cambridge Nutritional Sciences plc
More press releases
| 1 day | +5.24% | ||
| 1 week | +16.24% | ||
| Current month | +12.87% | ||
| 1 month | +18.00% | ||
| 3 months | +62.25% | ||
| 6 months | +125.74% | ||
| Current year | +62.25% |
1 week
3.20
4.00
1 month
3.204.00
Current year
2.304.00
1 year
1.664.00
3 years
1.6688.80
5 years
1.66126.95
10 years
1.66126.95
| Managers | Title | Age | Since |
|---|---|---|---|
Jag Grewal
CEO | Chief Executive Officer | 54 | 11-06-29 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jag Grewal
CEO | Chief Executive Officer | 54 | 11-06-29 |
Jeremy Millard
BRD | Director/Board Member | 53 | 19-02-28 |
Carolyn Rand
CHM | Chairman | 60 | 23-08-16 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-23 | 4 | +8.11% | 2 494 883 |
| 24-04-22 | 3.7 | +13.85% | 4,653,177 |
| 24-04-19 | 3.25 | 0.00% | 9,898 |
| 24-04-18 | 3.25 | -1.52% | 152,847 |
| 24-04-17 | 3.3 | -1.49% | 360,734 |
Delayed Quote London S.E., April 23, 2024 at 08:21 am EDT
More quotes
Cambridge Nutritional Sciences plc is a United Kingdom-based specialist medical diagnostics company. The Company develops, manufactures and markets diagnostic products associated with food sensitivity and gut health. The Company serves healthcare professionals and the consumer directly with a focus on health and nutrition products.
Calendar
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +62.25% | 10.86M | |
| +1.29% | 12.66B | |
| -17.03% | 7.04B | |
| +2.40% | 5.39B | |
| -2.51% | 4.45B | |
| +1.73% | 4.32B | |
| -50.32% | 3.31B | |
| +6.90% | 2.6B | |
| -16.69% | 2.01B | |
| -3.40% | 1.67B |
- Stock Market
- Equities
- ODX Stock
